S. ERDEM Et Al. , "The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?," Symposium on roboticsan New Technologies in Prostate Cancer , İstanbul, Turkey, 2018
ERDEM, S. Et Al. 2018. The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?. Symposium on roboticsan New Technologies in Prostate Cancer , (İstanbul, Turkey).
ERDEM, S., VEREP, S., YİTGİN, Y., TEFIK, T., Ozluk, Y., SANLI, O., ... ÖZCAN, F.(2018). The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology? . Symposium on roboticsan New Technologies in Prostate Cancer, İstanbul, Turkey
ERDEM, Selçuk Et Al. "The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?," Symposium on roboticsan New Technologies in Prostate Cancer, İstanbul, Turkey, 2018
ERDEM, Selçuk Et Al. "The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?." Symposium on roboticsan New Technologies in Prostate Cancer , İstanbul, Turkey, 2018
ERDEM, S. Et Al. (2018) . "The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?." Symposium on roboticsan New Technologies in Prostate Cancer , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={Selçuk ERDEM Et Al. }, title={The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?}, congress name={Symposium on roboticsan New Technologies in Prostate Cancer}, city={İstanbul}, country={Turkey}, year={2018}}